OGI's Pre-commercialization Business Development Fund (PBDF) is a unique and useful investment fund that is helping to enable the economic impact of outcomes of genomics and proteomics research projects and technology development. Specifically, it aims to provide early-stage funding as researchers move towards commercial applications and to speed up transfer of products from lab to marketplace. The fund invests up to $100K per project.
- Create economic results from genomics and proteomics research;
- Support scientific entrepreneurs;
- Broker partnerships between academe and industry; and
- Generate returns for future PBDF investments.
PBDF deadline for applications for the current round is February 10, 2012.
For more information, contact the Business Development team.